🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of the Degree of Regeneration After Partial Meniscectomy Based on Thin-layer MRI Image Segmentation and Reconstruction

Recruitingn/aAges 18 Years - 80 YearsAllBeijing Tsinghua Chang Gung Hospital
NCT07885943 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to employ 3.0T thin-slice high-resolution magnetic resonance imaging (MRI) and MIMICS image three-dimensionalreconstruction.Additionally, we examined the regeneration of the menisci in patients who had undergone partial meniscectomy of the knee joint at our hospital through retrospective follow-up and meniscus segmentation techniques. Proactive quantitative analysis of the meniscus in patients following partial meniscectomy of the knee joint 6 months and 12 months post-surgery. The relationship between the percentage of regenerated tissue and the location and extent of the surgical excision.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients who underwent partial resection of the meniscus using arthroscopy in our hospital and had follow-up thin-slice MRI scans within one week after surgery; no cases of joint infection, joint tumors, or other diseases were present. Exclusion Criteria: * Patients who did not undergo an MRI scan within one week after surgery for the removal of the inferior meniscus using arthroscopy, who had MRI scan contraindications or refused the procedure. Patients who underwent nuclear magnetic resonance (NMR) re-evaluation and had undergone surgery at least half a year prior to the commencement of this experiment.
💊

What it tests

  • No intervention measures.
📍

Where

1 site
Tsinghua Changgung Hospital, Beijing
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy